Vanguard Global Advisers
ETON icon

Vanguard Global Advisers’s Eton Pharmaceutcials ETON Stock Holding History

Vanguard Global Advisers’s Portfolio ETON Stock Details ETON Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$513K Buy
14,165
+5,174
+58% +$152K ﹤0.01% 2090
2026
Q1 		$222K Buy
+8,991
New +$157K ﹤0.01% 2395

Other funds holding ETON

OM
Opaleye Management Boston, Massachusetts $1.1B AUM 197.64% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.06B AUM 215.32% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $3B AUM 119.43% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
OAM
Oberweis Asset Management Lisle, Illinois $4.84B AUM 160.95% 1-Year Est. Return
NPT
National Philanthropic Trust Jenkintown, Pennsylvania $6.92B AUM 24.7% 1-Year Est. Return

Vanguard Global Advisers's ETON Position: Q2 2026 in Review

Vanguard Global Advisers increased its Eton Pharmaceutcials (ETON) stake by 58% in Q2 2026, buying an estimated $152K and bringing the position to 14,165 shares worth $513K. The position accounts for ﹤0.01% of the portfolio, ranked #2090.

Vanguard Global Advisers first reported a position in ETON in Q1 2026 and has held it in 2 quarters since. 164 funds tracked by Wall St. Rank hold ETON as of Q2 2026.

  • Vanguard Global Advisers held 14,165 shares of Eton Pharmaceutcials worth $513K as of Q2 2026.
  • Vanguard Global Advisers bought 5,174 Eton Pharmaceutcials shares in Q2 2026, an estimated $152K.
  • Eton Pharmaceutcials made up ﹤0.01% of Vanguard Global Advisers's portfolio in Q2 2026, its #2090 holding.
  • Vanguard Global Advisers first reported a position in Eton Pharmaceutcials in Q1 2026 and has held it in 2 quarters since.
  • 164 funds tracked by Wall St. Rank held Eton Pharmaceutcials as of Q2 2026.

Based on Vanguard Global Advisers's 13F filing for Q2 2026, filed 13 Aug 2026.